Domača stranMANKIND • NSE
Mankind Pharma Ltd
2480,00 ₹
30. jan., 15:57:33 GMT +5.30 · INR · NSE · Izjava
DelnicaVrednostni papir, ki kotira v IN
Prejšnji trg. dan.
2477,45 ₹
Dnevni razpon
2460,65 ₹ - 2534,10 ₹
Letni razpon
1901,05 ₹ - 3054,80 ₹
Tržna kapitalizacija
1,03 bil. INR
Povprečni obseg
654,81 tis.
Razm. P/E
47,06
Dividendna donosnost
-
Primarna borza
NSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(INR)dec. 2024Sprememba L/L
Prihodek
32,30 mrd.23,90 %
Stroški poslovanja
16,57 mrd.29,21 %
Čisti dohodek
3,80 mrd.−16,20 %
Čista dobičkovnost prihodkov
11,77−32,40 %
Earnings per share
9,44−16,53 %
EBITDA
7,34 mrd.27,38 %
Efektivna davčna stopnja
22,68 %
Skupna sredstva
Skupne obveznosti
(INR)dec. 2024Sprememba L/L
Denar. in kratkor. naložbe
47,27 mrd.103,22 %
Skupna sredstva
Skupne obveznosti
Celoten lastniški kapital
107,89 mrd.
Shares outstanding
402,36 mio.
Razmerje P/B
9,39
Donosnost sredstev
Donosnost kapitala
14,14 %
Neto sprememba denarnih sredstev
(INR)dec. 2024Sprememba L/L
Čisti dohodek
3,80 mrd.−16,20 %
Denar iz dejavnosti
Denar iz naložb
Denar iz financiranja
Neto sprememba denarnih sredstev
Prost denarni tok
Vizitka
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Generalni direktor
Datum ustanovitve
1991
Spletno mesto
Zaposleni
19.540
Iskanje
Počisti iskanje
Zapiranje iskanja
Googlove aplikacije
Glavni meni